Document:

EX-10.7

 EXHIBIT 10.7 

US FOODS HOLDING CORP. 

EMPLOYEE STOCK PURCHASE PLAN 
 1
Introduction 
 1.1 Purpose of the Plan 

The purpose of the Plan is to provide Employees with the opportunity to acquire Shares or an interest in Shares in the Company. 

Employees who participate in the Plan are given a right, called a Purchase Right, to buy Shares at the end of the specified Purchase Period.

 The Plan is a discretionary plan. Participation by any Employee is purely voluntary. 

1.2 Employee Stock Purchase Plan 

The Plan is intended to constitute an “employee stock purchase plan” within the meaning of Section 423 of the Code. The provisions of
the Plan will be construed so as to extend and limit participation in a manner consistent with that section of the Code. 
 1.3 Other
similar plans 
 The Company may establish similar plans for operation in other countries (“Sub-Plans”), as set out in
Section 18. The Sub-Plans may be scheduled to the rules of this Plan or set out in separate documents. The Plan is, however, a separate and independent plan from the Sub-Plans. 

1.4 Shares for the Plan and Sub-Plans 

The number of Shares authorized to be issued under the Plan in Section 8 applies in total to both the Plan and any Sub-Plans. The Committee
will determine, at its discretion, the method for allocating the Shares under the Plan and the Sub-Plans without stockholder approval. 
 2 Definitions

 2.1 As used in the Plan: 

“Account” means the bookkeeping account established for a Participant in accordance with Section 10.6. 

“Acquiring Company” means a person who obtains control of the Company. 

“Acquisition Date” means the end of the Purchase Period (as specified by the Committee in the invitation), at which time the
Purchase Right granted under the Plan may be exercised and Shares acquired on behalf of the Participant. 
 “Affiliate”
means, with respect to any Person, any other Person directly or indirectly controlling, controlled by or under common control with such first Person. For these purposes, “control” (including the terms “controlled by” and
“under common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction of the management policies of a Person by reason of ownership of voting securities, by contract or otherwise. 

“Board” means the Board of Directors of the Company or, where appropriate, a duly authorized committee of it. 

 “Business Day” means any day on which the New York Stock Exchange is open for
the transaction of business. 
 “Code” means the Internal Revenue Code of 1986, as amended. References to any provision of
the Code or regulation (including proposed regulation) include any successor provisions or regulations. 
 “Committee”
means the Compensation Committee of the Board or such other committee selected by the Board to administer the Plan. 

“Company” means US Foods Holding Corp, a company incorporated and organized under the laws of the state of Delaware and any
successor entity. 
 “Compensation” as defined in the US Foods 401(k) Plan, as may be amended from time to time 

 “Contribution” means the amount of after-tax payroll deduction an Employee has agreed to make, as set out in his
application for a Purchase Right. 
 “Dealing Restrictions” means restrictions imposed by statute, order, regulation or
Government directive, or by any code adopted by the Company, or any US or other regulatory requirement restricting dealings in Shares. 

“Eligible Employee” means an Employee who meets the requirements specified in the invitation to participate in the Offering
and as set forth in Section 3 of the Plan. 
 “Employee” means an individual employed by a Participating Company. 

“Grant Date” means a date selected by the Committee for an Offering to commence. 

“Offering” means the grant of Purchase Rights to acquire Shares under the Plan to Eligible Employees. 

“Parent” means a Person which is a “parent corporation” of the Company within the meaning of
Section 424(e) of the Code. 
 “Participant” means a person holding a Purchase Right, including Representatives. 

“Participating Companies” means: 

(i) any Subsidiary organized under the laws of any state of the United States of America, unless the Committee has determined a
Subsidiary is not designated to participate in the Plan; and 
 (ii) any other Subsidiary designated by the Committee to
participate in the Plan (as long as it is not participating in any Sub-Plan). 
 “Person” means any natural person, firm,
partnership, limited liability company, association, corporation, company, trust, business trust, governmental authority or other entity. 

“Plan” means this plan known as the US Foods Holding Corp. Employee Stock Purchase Plan. 

“Purchase Period” means a period of time specified in the invitation within an Offering, beginning on the Grant Date and
ending on the Acquisition Date, or such earlier date as may be established under Section 11 of the Plan. 
 “Purchase
Price” means the amount payable for each Share on the exercise of a Purchase Right calculated as described in Section 6 of the Plan. 

“Purchase Right” means a right to acquire Shares granted under the Plan. 

  
 2 

 “Representative” means the person entitled to receive the assets of a
Participant under a Participant’s will or the laws of intestate succession, in the case of a deceased Participant, or to act as a guardian or conservator for a Participant, in the case of a Participant who is found to be incompetent. 

“Securities Act” means the Securities Act of 1933, as amended. 

“Share” means a share of the common stock of the Company. 

“Sub-Plan” means any employee stock purchase plan established in accordance with Section 18. 

“Subsidiary” means a Person which is a “subsidiary corporation” of the Company within the meaning of Section 424(f)
of the Code. 
 Any references in the Plan to the masculine gender shall include references to the feminine gender and vice versa. 

2.2 Headings 
 Headings
will be ignored in construing the terms of the Plan. 
 3 Eligibility 

3.1 Eligible Employees 
 A
person will be eligible to participate if he or she: 
 3.1.1 is employed for the purposes of Section 423(b)(4) of the Code by a
Participating Company, including officers and directors, on the Grant Date; and 
 3.1.2 (i) has such qualifying period (if any) of
continuous service (not exceeding two years prior to the Grant Date), (ii) has such qualifying (if any) minimum number of customarily scheduled hours of work (not exceeding twenty), and/or (iii) such qualifying (if any) minimum number of months
customarily worked per calendar year (not exceeding five), in each case as the Committee may from time to time determine. 
 3.2
Restrictions on eligibility 
 A person will not be eligible for the grant of any Purchase Rights if, immediately after the grant of a
Purchase Right, the person owns stock possessing 5 percent or more of the total combined voting power or value of all classes of shares of the Company or any Subsidiary. For the purpose of this Section 3.2, the rules of Section 424(d) of the Code
apply in determining the share ownership of any Employee and the Shares which he or she may acquire under all outstanding Purchase Rights. Purchase Rights will be treated as stock owned by the person. 

4    Invitations 

4.1    Operation 

The Committee has discretion to decide whether the Plan will be operated. When the Committee operates the Plan it must invite all Eligible
Employees to apply to participate. 
 The invitation will continue to have effect in respect of subsequent Offerings under the Plan such
that a Participant who has withdrawn from an Offering under Section 10.4 may re-apply to join the Plan under Section 5.1 provided he or she continues to be an Eligible Employee. 

  
 3 

 4.2    Time when invitations may be made 

4.2.1    Invitations may be made at any such time as the Committee determines, subject to any
Dealing Restrictions. 
 4.2.2    If the Committee cannot make the invitation due to Dealing
Restrictions, the Committee may make the invitations at any time after the lifting of such restrictions. 

4.3    Form of invitation 

The invitation will specify:     

4.3.1    the Grant Date; 

4.3.2    the requirements a person must satisfy in order to be eligible to participate; 

4.3.3    the Purchase Price or how it is to be calculated; 

4.3.4    the length of the Offering, which must not exceed 27 months beginning with the Grant Date;

 4.3.5    how applications must be submitted and the closing date for applying to join the
Offering; 
 4.3.6    the maximum number, “if any, of Shares over which Purchase Rights may
be granted: 
 (i)    individually; 

(ii)    for the Offering; 

(iii)    taken in conjunction with Offerings under the Sub-Plans; or 

(iv)    for a specific Purchase Period; 

4.3.7    the maximum and minimum permitted Contribution which can be specified in a currency or as a
percentage of the Participant’s Compensation; 
 4.3.8    when and how frequently the payroll
deductions will be made; 
 4.3.9    the Acquisition Date at the end of the Offering when the
Shares will be acquired; and 
 4.3.10    any other terms, consistent with the terms and
conditions of the Plan. 
 The invitation and Offering must comply with the requirements of Section 423(b)(5) of the Code. 

4.4    Limit on participation 

4.4.1    No person may be granted a Purchase Right which permits his rights to purchase Shares under
all plans of the Company, any Subsidiary or Parent of the Company that are qualified under Section 423 of the Code to exceed US$25,000 of the Fair Market Value of such Shares, determined at the time the Purchase Right is granted, for each
calendar year in which such Purchase Right is outstanding at any time. 

  
 4 

 4.4.2    To the extent necessary to comply with this
requirement, the Committee may: 
 (i)    cause a Participants Contributions to be decreased in respect
of any Offering; or 
 (ii)    take other actions it considers necessary to ensure compliance with
Section 423 of the Code. 
 5    Enrollment 

5.1    Form of application 

An application for a Purchase Right will be made in writing, or electronically, in a form specified by the Committee and will require the
Eligible Employee to state: 
 5.1.1    the Contribution he or she wishes to make; 

5.1.2    that his proposed Contribution, when added to any contributions he or she makes under any
other stock purchase plans of the Company, its Subsidiaries or its Parent, will not exceed the maximum permitted under Section 423 of the Code. 

An application in the form determined by the Committee which is improperly completed or late may be rejected. 

5.2    Subsequent Offerings 

Unless the Participant withdraws from an Offering under Section 10.4, the Participant’s application is deemed to apply in respect of any
subsequent Offerings if they are made available by the Company. 
 5.3    Incorporation of terms 

The terms of each Offering will include, through incorporation by reference, the provisions of this Plan. 

6    Purchase Price 

6.1    Setting the price 

The Committee will determine the Purchase Price (or the method by which it shall be determined) at the beginning of the Offering. The Purchase
Price must not be less than 85 percent of the Fair Market Value of a Share at the Acquisition Date. 
 6.2    Fair
Market Value 
 “Fair Market Value” on any particular day means the closing selling price for a Share on the New York
Stock Exchange as reported in The Wall Street Journal or such other recognized source as the Committee determines on the following Business Day. 

If no selling price is reported for a particular date, “Fair Market Value” will be the closing selling price for a Share on the
closest preceding Business Day for which such selling price is provided unless otherwise determined by the Committee. If the Shares are listed on any established stock exchange of a national market system (but they are not listed on the New York
Stock Exchange), their “Fair Market Value” shall be the closing selling price for the Shares, as quoted on such exchange (or the exchange with the greatest volume of trading in Shares) or system on the date of such determination, as
reported in The Wall Street Journal or such other recognized source as the Committee determines. If the Share is no longer listed on an established market, “Fair Market Value” of a Share will be determined in good faith by the
Committee. 

  
 5 

 7    Grant of Purchase Right 

7.1    Grant 

Unless there has been scaling down as described in Section 9, or the Committee decides not to proceed with an Offering, for example, because
there are not enough Shares, the Committee must, on the Grant Date, grant to each Eligible Employee who has submitted and not withdrawn a valid application a Purchase Right to acquire, at the Purchase Price, the number of Shares for which the
Eligible Employee has applied (or is deemed to have applied) based on the amount of Contributions he or she will make during the Offering. 

The Committee will not grant a Purchase Right to anyone who is not an Eligible Employee on the Grant Date. If the Committee tries to do so,
the grant will be void. 
 7.2    Correction 

Any grant of a Purchase Right in excess of the limit in Section 8 or Section 4.4 may be adjusted in any way so as to not exceed those limits.

 7.3    Transferability 

Purchase Rights are not transferable by the Participant otherwise than by will or the laws of descent and distribution, and shall only be
exercisable during the Participant’s lifetime by the Participant. 
 8    Shares available for the Plan 

8.1    Limit required by IRS rules 

Shares that may be issued or sold pursuant to Purchase Rights granted under the Plan and any Sub-Plan shall not exceed in the aggregate
1,250,000 Shares of the Company. This number is subject to the provisions of Section 14.3 relating to adjustments upon changes in capitalization. 

8.2    Exclusions 

Where a Purchase Right is terminated or lapses without being exercised, these Shares are ignored when calculating the limits in this Section 8.

 8.3    Types of Shares 

The Shares subject to the Plan may be Shares that have been authorized but unissued, Shares that have been bought, or treasury shares. 

9    Scaling down 

9.1    Method 

If valid applications are received for a total number of Shares in excess of any maximum number specified in the invitation under Section 4.3,
Section 4.4 or any limit under Section 8 the Committee will scale down applications by choosing one or more of the following methods: 

9.1.1    reducing the proposed Contributions by the same proportion to an amount not less than the
minimum specified in the invitation; or 
 9.1.2    reducing the proposed Contributions to a
maximum amount chosen by the Committee, which must not be less than the minimum specified in the invitation; or 

9.1.3    using other methods, but these must treat Eligible Employees fairly. 

  
 6 

 9.2 Insufficient Shares 

If, having scaled down as described in Section 9.1, the number of Shares available is insufficient to enable Purchase Rights to be granted to
all Eligible Employees making valid applications, the Committee may decide not to grant any Purchase Rights. 
 10 Payroll deductions 

10.1 Start and end 

Contributions will be deducted from payroll on each pay date during an Offering (unless terminated early in accordance with this section) or
such other dates as the Committee may decide. All Contributions are made on an after-tax basis. 
 10.2 Suspending Contributions 

A Participant may request to suspend making Contributions at any time prior to the Acquisition Date by notifying the Company in the form and
manner designated by the Company. On the Acquisition Date the Participant’s Purchase Right will be exercised and Shares purchased to the extent of the Contributions made until the suspension date, unless a Participant withdraws from the
Offering in accordance with Section 10.4. Any suspension under this Section 10.2 will take effect no later than the first pay date following ten (10) business days from the Company’s receipt of the change form and shall be effective for the
entire duration of the Offering in which it is made (but not for any succeeding Offering), unless the Committee determines otherwise. 
 A
Participant shall not be permitted to make up any missed Contributions as a result of suspension under this Section 10.2 or otherwise. 

10.3 Changing Contributions 

During an Offering, a Participant may request to decrease the rate of his Contributions for the remaining part of the Offering and any
succeeding Offerings, by completing or filing with the Company a change form authorizing a change in the Contribution. The new rate of Contribution will take effect no later than the first pay date following ten (10) business days from the
Company’s receipt of the change form. A Participant is permitted to decrease Contributions once per Offering. 
 10.4 Withdrawal
from an Offering 
 A Participant may request to withdraw from an Offering at any time prior to the Acquisition Date by notifying the
Company in the form and manner designated by the Company. The request will take effect no later than ten (10) business days following the Company’s receipt of the request. For the avoidance of doubt, the Company is not obliged to process a
request to withdraw from an Offering if the request is submitted later than ten (10) days prior to an Acquisition Date. If not processed prior to the relevant Acquisition Date, the request will take effect in respect of the next Offering. 

All of the Participant’s Contributions credited to his Account will be paid to him no later than 30 days after receipt of his notice of
withdrawal and his Purchase Right for the current Offering will be automatically terminated. No further Contributions for the purchase of Shares will be permitted or made during the Offering. Unless otherwise required by local law as determined by
the Committee in its sole discretion, no interest or earnings shall be payable upon a Participant’s withdrawal from an Offering. 

Unless the Committee sets forth limits on the frequency of a Participant’s ability to withdraw from an Offering, a Participant’s
withdrawal from an Offering will not have any effect upon his eligibility to participate in the next Offering. 

  
 7 

 10.5 Continued participation 

If so specified on the application, the Participant will continue to participate in successive Offerings unless terminated as provided in this
Section 10. 
 10.6 The Account 

The Contributions will be credited to a bookkeeping account for the Participant and may be deposited with the general funds of the Company or
the Participating Company or, if the Committee so decides, with a banking institution or custodian as designated by the Committee. No interest or earnings shall be paid or credited to the Participant’s Account with respect to any payroll
deductions except where required by local law as determined by the Committee. 
 10.7 Compliance with Section 423 

A Participant’s Contributions will, at any time, be decreased to the extent necessary to comply with Section 423(b)(8) of the Code and
Section 4.4. Contributions shall recommence at the rate provided in the Participant’s application at the beginning of the first Purchase Period which is scheduled to end in the following calendar year, unless otherwise withdrawn by the
Participant under Section 10.4 or changed under Section 10.3. 
 10.8 Approved leave of absence 

During an approved leave of absence, a Participant may continue to participate in the Plan but may elect to suspend Contributions in accordance
with Section 10.2 during such leave period. 
 For the purposes of this Section 10.8, “approved leave of absence” means an
Employee’s leave of absence (for example, military leave, maternity leave or sick leave) with the prior approval of an authorized person of his employer, during which period the Employee’s employment relationship is treated as continuing
for the purposes of the Plan. 
 However, if the period of leave exceeds 90 days and the individual’s right to re-employment is not
guaranteed either by statute or by contract, the employment relationship is deemed to terminate for the purposes of the Plan on the first day immediately following such 90-day period. 

11 Termination of employment 
 11.1
General rule on termination and death 
 A Purchase Right lapses immediately if a Participant dies or ceases to be employed by a
Participating Company (for example, if he or she resigns). The Contributions credited to his Account will be returned to him or his Representative, as appropriate, without interest, no later than 30 days following the termination of employment and
his Purchase Right will be automatically terminated. 
 11.2 Beneficiary designation 

Notwithstanding Section 11.1, the Company may allow Participants to designate a beneficiary to receive the Contributions credited to the
Participant and any Shares issued pursuant to the Plan which are held by a custodian on behalf of the Participant in the event of the Participant’s death, in accordance with such rules as it shall establish from time to time. 

12 Exercise of Purchase Right 
 12.1
Exercise 
 Unless a Participant withdraws from the Plan as provided in Section 10.4, his Purchase Right will be exercised automatically
on each Acquisition Date, and the maximum number of whole Shares subject to the Purchase Right will be purchased at the applicable Purchase Price with the accumulated Contributions in his 

  
 8 

 
Account. The Purchase Right cannot be exercised in part. Any surplus in the Account which is insufficient to purchase a whole Share will be either paid directly to the Participant in cash or
carried forward, in either case pursuant to rules established from time to time. However, there are some conditions and exceptions to this general rule on exercise (See, Sections 12.2 and 12.3). 

12.2 Contributions 
 A
Participant may exercise his Purchase Right only using funds equal to or less than the Contributions for the applicable Offering. A Participant can only use Contributions made before the Acquisition Date applicable to the Purchase Right. 

12.3 Registration compliance 

No Purchase Right may be exercised unless the Shares to be issued or transferred upon exercise are covered by an effective registration
statement pursuant to the Securities Act or are eligible for an exemption from the registration requirements, and the Plan is in material compliance with all applicable federal, state, foreign and other securities and other laws applicable to the
Plan. 
 If, on an Acquisition Date during any Offering, the Shares are not registered or exempt or the Plan is not in such compliance, no
Purchase Rights granted under the Plan or any Offering shall be exercised on the Acquisition Date. The Acquisition Date will be delayed until the Shares are subject to such an effective registration statement or exempt, and the Plan is in such
compliance. The Acquisition Date will in no event be more than 27 months from the Grant Date. 
 If, on the Acquisition Date under any
Offering, as delayed to the maximum extent permissible, the Shares are not registered or exempt and the Plan is not in such compliance, no Purchase Rights will be exercised, and all Contributions accumulated during the Offering (reduced to the
extent, if any, such deductions have been used to acquire Shares) will be distributed to the Participants with any interest. 
 12.4
Lapse 
 A Purchase Right will lapse and automatically terminate on the earliest of the dates specified below: 

12.4.1 the date on which the person ceases to be an Employee; 

12.4.2 the date on which the Participant gives notice under Section 10.4 that he or she intends to withdraw from the
Plan; and 
 12.4.3 as provided in Section 14.1. 

13 Acquisition of Shares 
 13.1 Issue
or transfer 
 The Shares may be issued to a Participant or transferred to a custodian on behalf of the Participant. Subject to Section
12.3: 
 13.1.1 Shares to be issued to a Participant following the exercise of a Purchase Right must be issued within
30 days of the Acquisition Date; and 
 13.1.2 if Shares are to be transferred to a custodian following the exercise
of a Purchase Right, the Committee must effect this transfer within 30 days of the Acquisition Date. 

  
 9 

 13.2 Rights 

13.2.1 Shares issued to a Participant on exercise of a Purchase Right rank equally in all respects with the Shares in
issue on the date of issue. They are not entitled to any rights attaching to Shares by reference to a record date preceding the date of issue. 

13.2.2 Where Shares are to be transferred to a custodian on the exercise of a Purchase Right, Participants are entitled
to all rights attaching to the Shares by reference to a record date after the transfer date. They are not entitled to any rights before that date. 

13.3 Certificate of incorporation and bylaws 

Any Shares acquired on the exercise of Purchase Rights are subject to the certificate of incorporation and bylaws of the Company in effect from
time to time. 
 13.4 Listing 

If and so long as the Shares are listed on the New York Stock Exchange or on any other stock exchange where Shares are traded, the Company must
apply for listing of any Shares issued pursuant to the Plan prior to or as soon as practicable after their issuance. 
 14 Corporate events 

14.1 Change in Control 

Upon the occurrence of a Change in Control (as defined below), the Board, in its sole discretion may: 

14.1.1 Provide that each Purchase Right shall be assumed or an equivalent Purchase Right shall be substituted by the
successor corporation or parent or subsidiary of such successor corporation; 
 14.1.2 Establish a date prior to the
consummation of the Change in Control that shall be treated as the Acquisition Date, and all outstanding Purchase Rights shall be deemed exercised on such date; or 

14.1.3 the Participant’s accumulated Contributions and any interest (if applicable) will be returned to the
Participant as soon as practicable, the Purchase Rights will be cancelled and the Offering will terminate. 
 If a Change in Control is
pending, the Committee may delay the commencement of an Offering. 
 14.2 Liquidation or dissolution of the Company 

If the Company passes a resolution for its liquidation or dissolution, any Offering shall terminate and Purchase Rights will be cancelled as at
that date. Any Contributions and interest (if applicable), will be returned to the Participant as soon as practicable. 
 14.3 Change in
the securities of the Company 
 If any change is made in the Shares of the Company (including by reason of merger, consolidation,
reorganization, recapitalization, stock dividend, stock split, combination of shares, change in corporate structure or other transaction), the Committee shall make an equitable and proportionate anti-dilution adjustment to offset any resultant
change in the pre-share price of the Shares. Such mandatory adjustment may include a change in the type(s), class(es) and the maximum number of Shares subject to the Plan pursuant to Section 8, and shall adjust the type(s), class(es) number of
Shares and purchase limits of each outstanding Purchase Right and the Purchase Price in any manner equitable to the Participants; this may include retrospective adjustments. If making such an adjustment, the Committee may consider any consideration
received by the Company in the transaction. Adjustments may only be made if consistent with the applicable rules under Sections 423 and 424 of the Code. 

  
 10 

 The Company may notify the Participant of any adjustment made under this Section 14.3. 

14.4 Terms used 
 For the
purpose of this Section 14: 
 “Change in Control” means the first to occur of the following events after the adoption of
the Plan: 
 14.4.1 the acquisition (whether by purchase, merger, consolidation, combination, or other similar
transaction) by any Person of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act of 1934, as amended (the “Exchange Act”)) of more than 50% (on a fully diluted basis) of either (A) the then
outstanding Shares, taking into account as outstanding for this purpose such Shares issuable upon the exercise of options or warrants, the conversion of convertible stock or debt, and the exercise of any similar right to acquire such Shares or (B)
the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors; provided, however, that for purposes of this Plan, the following acquisitions shall not constitute a
Change in Control: (I) any acquisition by the Company or any Affiliate; (II) any acquisition by any employee benefit plan sponsored or maintained by the Company or any Affiliate; or (III) in respect of an equity award held by a particular
participant in an employee incentive plan, any acquisition by such participant or any group of Persons including such participant (or any entity controlled by such participant or any group of Persons including the participant); 

14.4.2 during any period of twelve (12) months, individuals who, at the beginning of such period, constitute the Board
(the “Incumbent Directors”) cease for any reason to constitute at least a majority of the Board, provided that any person becoming a director subsequent to the date hereof, whose election or nomination for election was
approved by a vote of at least two-thirds of the Incumbent Directors then on the Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for director, without written objection
to such nomination) shall be an Incumbent Director; provided, however, that no individual initially elected or nominated as a director of the Company as a result of an actual or threatened election contest, as such terms are used in Rule
14a-12 of Regulation 14 A promulgated under the Exchange Act, with respect to directors or as a result of any other actual or threatened solicitation of proxies or consents by or on behalf of any person other than the Board shall be deemed to be an
Incumbent Director; or 
 14.4.3 the sale, transfer, or other disposition of all or substantially all of the assets of
the Company to any Person that is not an Affiliate of the Company. 
 15 General 

15.1 Notices 

15.1.1 Any notice or other document which has to be given to an Eligible Employee or Participant under or in connection
with the Plan may be: 
 (i) delivered or mailed to him at his address according to the records of his employing company; or

 (ii) sent by e-mail or fax to any e-mail address or fax number which, according to the records of his employing company,
is used by him, 
 or in either case such other address which the Company considers appropriate. 

 

  
 11 

 15.1.2 Any notice or other document which has to be given to the Company
or other appointed agent under or in connection with the Plan may be delivered or mailed to it at such place as the Committee or its duly appointed agent may from time to time decide and notify to Participants or sent by e-mail or fax to any e-mail
address or fax number notified to the sender. 
 15.1.3 Notices mailed will be deemed to have been given on the
earlier of the date of actual receipt and the seventh day after the mailing date. 
 15.1.4 Notices sent by e-mail or
fax, in the absence of evidence of non-delivery, will be deemed to have been received on the day after sending. 
 15.2 Documents sent to
stockholders 
 The Company may send to Participants copies of any documents or notices normally sent to the holders of its Shares. 

15.3 Costs 
 The Company
or a Participating Company (as appropriate) will pay the costs of establishing and administering the Plan. The Company may require each other Participating Company to reimburse the Company for any costs incurred in connection with the grant of
Purchase Rights to, or exercise of Purchase Rights by, Employees of that Participating Company. 
 15.4 Terms of employment 

15.4.1 For the purposes of this Section 15.4, “Employee” means any employee of the Company or any
Subsidiary or associated company of the Company. 
 15.4.2 This Section 15.4 applies during an Employee’s
employment and after the termination of an Employee’s employment, whether or not the termination is lawful. 

15.4.3 Nothing in this Section or the operation of the Plan forms part of any contract of employment of an Employee. The
rights and obligations arising from the employment relationship between the Employee and the Participating Company are separate from, and are not affected by, the Plan. Participation in the Plan does not create any right to, or expectation of,
continued employment. 
 15.4.4 Subject to Section 4.1, no Employee has a right to participate in the Plan.
Participation in the Plan or the grant of Purchase Rights on a particular basis in any year does not create any right to or expectation of participation in the Plan or the grant of Purchase Rights on the same basis, or at all, in any future year.

 15.4.5 The terms of the Plan do not entitle the Employee to the exercise of any discretion by the Company, a
Participating Company or the Committee in his favor. 
 15.4.6 No Employee will have a claim or right of action in
respect of any decision, omission or exercise of discretion, not relating to an existing Purchase Right, which may operate to the disadvantage of the Employee. 

15.4.7 No Employee has any right to compensation for any loss in relation to the Plan, including any loss in relation
to: 
 (i) any loss or reduction of rights or expectations under the Plan in any circumstances (including lawful or unlawful
termination of employment); 

  
 12 

 (ii) any exercise of discretion or a decision made in relation to a Purchase
Right or to the Plan, or any failure to exercise discretion or make a decision; or 
 (iii) the operation, suspension,
termination or amendment of the Plan. 
 15.4.8 Participation in the Plan is permitted only on the basis that the
Participant accepts all terms and conditions of the Plan, including this Section 15.4. By participating in the Plan, an Employee waives all rights under the Plan, other than the rights expressly granted herein or in any invitation to participate in
accordance with the express terms of this Section in consideration for, and as a condition of, the grant of a Purchase Right under the Plan. 

15.4.9 Nothing in this Plan confers any benefit, right or expectation on a person who is not an Employee. No such third
party has any rights to enforce any term of this Plan. This does not affect any other right or remedy of a third party which may exist. 

15.4.10 Benefits under this Plan shall not be taken into account for the purpose of determining any benefits under any
benefit plan unless such plan (or arrangement) specifically provides otherwise. 
 15.5 Corporate actions 

The existence of any Purchase Right shall not affect in any way the right or power of the Company or its stockholders to make or authorize any
or all adjustments, recapitalizations, reorganizations or other changes in the Company’s capital structure or preferred or prior preference stock ahead of or convertible into, or otherwise affecting, the Shares or the rights of them, or the
dissolution or liquidation of the Company or any sale or transfer of all or any part of its assets or business, or any other corporate act or proceeding, whether of a similar character or otherwise. 

15.6 Employee trust 
 The
Company and any Subsidiary may provide money to the trustee of any trust or any other person to enable the trust or him to acquire Shares for the purposes of the Plan, or enter into any guarantee or indemnity for those purposes, to the extent
permitted by law. 
 15.7 Withholding 

Unless the Participant discharges the liability himself, the Company or a Participating Company, the trustee of any trust or other third party
administrator may withhold any amount and make any arrangements as it considers necessary to meet any tax withholding obligation of the Company in respect of Purchase Rights. These arrangements include the sale of any Shares on behalf of a
Participant. 
 15.8 Data privacy 

By participating in the Plan the Participant consents to the holding and processing of personal data provided by the Participant to the
Company, any Subsidiary or associated company trustee or third party service provider, for all purposes relating to the operation of the Plan. These include, but are not limited to: 

15.8.1 administering and maintaining Participant records; 

15.8.2 providing information to an associated company, trustees of any trust, registrars, brokers or other third party
administrators of the Plan; 
 15.8.3 providing information to future purchasers of the Company or the business in
which the Participant works; and 

  
 13 

 15.8.4 transferring information about the Participant to a country or
territory outside the United States of America that may not provide the same statutory protection for the information as the Participant’s home country. 

15.9 Offset 
 To the
extent permitted by law, the Company shall have the absolute right to withhold any amounts payable to any Participant under the terms of the Plan to the extent of any amounts owed for any reason by such Participant to the Company or Participating
Company and to set off and apply the amounts so withheld from payment of any such amount owed to the Company or Participating Company, whether or not such amount shall then be immediately due and payable and in such order or priority as among such
amounts owed as the Company, in its sole discretion, shall determine. 
 15.10 Repurchase 

The Company shall have no obligation to repurchase from any Participant any Shares acquired under the Plan. 

15.11 Legal compliance 

If in the opinion of counsel for the Company, it is necessary or desirable in order to comply with applicable laws or regulations relating to
securities or exchange control, the Company may: 
 15.11.1 require the Participant to provide confirmation of
compliance with such local laws and regulations, without which the Purchase Right may lapse; and/or 
 15.11.2 upon
the exercise of the Purchase Right, substitute cash equal to the value of any spread (less any tax and social security contributions) for any Shares. 

15.12 Crediting Service 

In the event of the adoption of the Plan by an Acquiring Company, the merger or consolidation of another company with a Participating Company,
or the acquisition by the Company of another company, the Committee shall determine the extent, if any, to which employees affected by the event shall be credited under the Plan with service rendered to his employer prior to the event. 

16 Administration 
 16.1
Committee’s powers 
 The Committee will administer the Plan. Subject to the provisions of the Plan, the Committee has the power:

 16.1.1 to determine when and how Purchase Rights to acquire Shares will be granted and the provisions of each
Offering of such Purchase Rights; 
 16.1.2 to convert, when necessary, any value denominated in US dollars and cents
to an equivalent currency based on a currency exchange rate that it selects for such purpose; 
 16.1.3 to designate
from time to time which Subsidiaries shall become Participating Companies; 
 16.1.4 to construe and interpret the
Plan and Purchase Rights granted under the Plan, and to establish, amend and revoke rules and regulations for the administration of the Plan. The Committee, in the exercise of this power, may correct any defect, omission or inconsistency in the
Plan; and 

  
 14 

 16.1.5 generally, to exercise such powers and to perform such acts as it
deems necessary or expedient to promote the best interests of the Company and other Participating Companies and to carry out the intent that the Plan be treated as an “employee stock purchase plan” within the meaning of Section 423 of the
Code. 
 16.2 Committee’s decision final and binding 

All determinations of the Committee are final and binding on Employees, Participants and any other party claiming a right or a benefit under
the Plan or in connection with any Offering. 
 16.3 Indemnification of Committee 

To the extent permitted by law, the Company shall indemnify the members of the Committee from all claims for liability, loss or damage
(including payment of expenses in connection with the defense again such claim) arising from any act or failure to act under the Plan, provided any such member shall give the Company an opportunity, at its own expense, to handle and defend such
claims. This shall not include actions which could be held to include criminal liability under applicable law. The provision of this Section 16.3 shall survive the termination of the Plan under Section 17. 

17 Changing the Plan and Termination 

17.1 Changing the Plan 

The Committee may at any time change the Plan in any way. The Company shall obtain stockholder approval of such amendments in such a manner and
to such a degree as required and to the extent necessary to comply with Section 423 of the Code (or any other applicable law). The Plan may not be amended in any manner that will retroactively impair or otherwise adversely affect the rights of
any person to benefits under the Plan which have accrued prior to the date of such action. 
 17.2 Notice 

The Committee may give written notice of any changes made to any Participant affected. 

17.3 Termination of the Plan 

The Committee may terminate the Plan at any time; provided, that no termination will adversely affect the rights of any person to benefits
under the Plan which have accrued prior to the date of such termination. For the avoidance of doubt, Purchase Rights granted before such termination will continue to be valid and exercisable as described in this Section. 

18 Overseas Participants 
 18.1
Establishing plans 
 The Committee may establish plans to operate overseas either by scheduling sub-plans to the Plan, or adopting
separate plans in accordance with the authority given by stockholders (together “Sub-Plans”). This includes: 

18.1.1 designating from time to time which Subsidiaries will participate in a particular Sub-Plan; 

18.1.2 determining procedures for eligible employees to enroll in or withdraw from a Sub-Plan, setting or changing
payroll deduction percentages, and obtaining necessary tax withholdings; and 
 18.1.3 allocating the available Shares
under the Plan to the Sub-Plans for particular offerings. 

  
 15 

 18.2 Overseas laws 

If, in the opinion of the Committee, local laws or regulations cause participation in the Plan to become unduly onerous for the Company, a
Participating Company or a Participant, the relevant Purchase Right will not be exercised and all Contributions accumulated during the Offering (reduced to the extent, if any, such deductions have been used to acquire Shares) will be distributed to
the Participant without any interest (unless required by applicable law). No right to compensation for loss of benefit will arise as a result of such an event. 

19 Governing Law 
 The laws of the state
of Delaware (without regard to its conflicts of laws rules) govern the Plan and all Purchase Rights and their construction. The courts of the state of Delaware have non-exclusive jurisdiction in respect of disputes arising under or in connection
with the Plan or any Purchase Right. 

  
 16EX-10.1

 Exhibit 10.1 
  

 
 AMENDED AND RESTATED 

STOCKHOLDERS AGREEMENT 

of 
 US FOODS HOLDING
CORP. 
 dated as of June 1, 2016 
  

 

 TABLE OF CONTENTS 

 

							
	 	  	Page	 
		
	 RECITALS
	  	 	1	  
		
	 ARTICLE I DEFINITIONS
	  	 	1	  
	 SECTION 1.1.
	  	Certain Defined Terms	  	 	1	  
	 SECTION 1.2.
	  	Other Definitional Provisions	  	 	6	  
		
	 ARTICLE II CORPORATE GOVERNANCE
	  	 	6	  
	 SECTION 2.1.
	  	Board Representation	  	 	6	  
	 SECTION 2.2.
	  	Committees	  	 	9	  
	 SECTION 2.3.
	  	[Reserved]	  	 	9	  
	 SECTION 2.4.
	  	Change in CEO	  	 	9	  
	 SECTION 2.5.
	  	Consent Rights	  	 	10	  
	 SECTION 2.6.
	  	Available Financial Information	  	 	13	  
	 SECTION 2.7.
	  	Access	  	 	14	  
	 SECTION 2.8.
	  	Termination of Rights	  	 	15	  
		
	 ARTICLE III MISCELLANEOUS
	  	 	15	  
	 SECTION 3.1.
	  	Stockholder Indemnification; Reimbursement of Expenses	  	 	15	  
	 SECTION 3.2.
	  	Termination	  	 	16	  
	 SECTION 3.3.
	  	Amendments and Waivers	  	 	17	  
	 SECTION 3.4.
	  	Successors, Assigns and Transferees	  	 	17	  
	 SECTION 3.5.
	  	[Reserved]	  	 	17	  
	 SECTION 3.6.
	  	Notices	  	 	17	  
	 SECTION 3.7.
	  	Further Assurances	  	 	19	  
	 SECTION 3.8.
	  	Entire Agreement	  	 	19	  
	 SECTION 3.9.
	  	Restrictions on Other Agreements; Bylaws	  	 	19	  
	 SECTION 3.11.
	  	Delays or Omissions	  	 	20	  
	 SECTION 3.12.
	  	Governing Law; Jurisdiction; Waiver of Jury Trial	  	 	20	  
	 SECTION 3.13.
	  	Severability	  	 	20	  
	 SECTION 3.14.
	  	Enforcement	  	 	20	  
	 SECTION 3.15.
	  	Titles and Subtitles	  	 	20	  
	 SECTION 3.16.
	  	No Recourse	  	 	20	  
	 SECTION 3.17.
	  	Counterparts; Facsimile Signatures	  	 	21	  
		
	 Exhibits
	  			
		
	 Exhibit A — Assignment and Assumption Agreement
	  			

  
 - i - 

 THIS STOCKHOLDERS AGREEMENT (this “Agreement”) is entered as of June 1,
2016, among US FOODS HOLDING CORP., a Delaware corporation (the “Company”), and each of the stockholders of the Company whose name appears on the signature pages hereof (each, a “Stockholder” and collectively, the
“Stockholders”). 
 RECITALS 

WHEREAS, pursuant to the Stock Purchase Agreement, dated May 2, 2007 (the “Purchase Agreement”), by and between Restore
Acquisition Corp., a Delaware corporation and wholly owned subsidiary of the Company (“Restore”), Ahold U.S.A., Inc. and Koninklijke Ahold N.V. (“Ahold”), Restore acquired all of the outstanding shares of common
stock of U.S. Foodservice, Inc., a Delaware corporation (“USF”), and certain related trademarks described in the Purchase Agreement (the “Acquisition”); 

WHEREAS, immediately following the Acquisition, Restore merged with and into USF and USF was the surviving corporation of the merger and
wholly-owned subsidiary of the Company; 
 WHEREAS, the Company, USF, and the Stockholders previously entered into the USF Holding Corp.
Stockholders Agreement, dated as of July 3, 2007 (the “Initial Agreement”), establishing certain terms and conditions upon which the shares of Common Stock (as defined below) would be held, including provisions restricting the
transfer of shares of Common Stock, and providing for certain other matters; 
 WHEREAS, the Company is undertaking an underwritten initial
public offering (the “IPO”) of shares of Common Stock; and 
 WHEREAS, in connection with, and effective upon, the date of
the completion of the IPO (the “Closing Date”), pursuant to Section 5.3 of the Initial Agreement, the Company and the Stockholders wish to set forth certain understandings between such parties, including with respect to certain
governance matters. 
 NOW, THEREFORE, in consideration of the foregoing recitals and of the mutual promises hereinafter set forth, the
Company and the Stockholders hereby agree as follows: 
 ARTICLE I 

DEFINITIONS 
 SECTION
1.1. Certain Defined Terms. As used herein, the following terms shall have the following meanings: 

“Affiliate” means, with respect to any Person, any other Person directly or indirectly controlling, controlled by or under
common control with, such Person. 
 “Annual Budget” has the meaning assigned to such term in Section 2.6(a)(ii). 

 “beneficial owner” or “beneficially own” has the meaning given
such term in Rule 13d-3 under the Exchange Act and a Person’s beneficial ownership of Common Stock or other Voting Securities of the Company shall be calculated in accordance with the provisions of such Rule; provided, however,
that for purposes of determining beneficial ownership, (i) a Person shall be deemed to be the beneficial owner of any security which may be acquired by such Person, whether within sixty (60) days or thereafter, upon the conversion, exchange or
exercise of any warrants, options, rights or other securities and (ii) no Person shall be deemed to beneficially own any security solely as a result of such Person’s execution of this Agreement. 

“Board” means the Board of Directors of the Company. 

“Business Day” means any day that is not a Saturday, a Sunday or other day on which banks are required or authorized by law
to be closed in the City of New York. 
 “Bylaws” means the Bylaws of the Company, as in effect on the date hereof and as
the same may be amended, supplemented or otherwise modified from time to time in accordance with the terms thereof, the terms of the Charter and the terms of this Agreement. 

“CD&R Investors” means Clayton, Dubilier & Rice Fund VII, L.P., Clayton, Dubilier & Rice Fund VII
(Co-Investment), L.P., CD&R Parallel Fund VII, L.P., CDR USF Co-Investor L.P., and CDR USF Co-Investor No. 2, L.P. 

“CD&R” means Clayton, Dubilier & Rice, Inc. 

“CD&R Designee” means any Director designated by the CD&R Investors pursuant to Section 2.1(a) of this Agreement.

 “CEO” means the Chief Executive Officer of the Company in office from time to time. 

“CEO Designee” has the meaning assigned to such term in Section 2.1(a). 

“Chairman” has the meaning assigned to such term in Section 2.1(a). 

“Change of Control” means the first to occur of the following events: (i) the sale of all or substantially all of the assets
of the Company to any Person (or group of Persons acting in concert), other than to (x) the Investors or their respective Affiliates or (y) any employee benefit plan (or trust forming a part thereof) maintained by the Company or its Affiliates or
other Person of which a majority of its voting power or other equity securities is owned, directly or indirectly, by the Company (any Person described in the foregoing clauses (x) or (y), an “Affiliated Person”); or (ii) a sale by
the Company, any of the Investors or any of their respective Affiliates to a Person (or group of Persons acting in concert) of Common Stock, or a merger, consolidation or similar transaction involving the Company, in any case, that results in more
than 50% of the Common Stock of the Company (or any resulting company after a merger) being held by a Person (or group of Persons acting in concert) that does not include an Affiliated Person; in any event, which results in the Investors and their
respective Affiliates or such employee benefit plan ceasing to hold the ability to elect a majority of the members of the Board. 

  
 2 

 “Charter” means the Amended and Restated Certificate of Incorporation of the
Company, as in effect on the date hereof and as the same may be amended, supplemented or otherwise modified from time to time in accordance with the terms thereof and the terms of this Agreement. 

“Closing Date” has the meaning set forth in the recitals. 

“Committee” has the meaning assigned to such term in Section 2.2(a). 

“Common Stock” means the common stock, par value $0.01 per share, of the Company and any securities issued in respect
thereof, or in substitution therefor, in connection with any stock split, dividend or combination, or any reclassification, recapitalization, merger, consolidation, exchange or other similar reorganization. 

“Company” has the meaning assigned to such term in the recitals. 

“Company Competitor” means any Person that is primarily engaged in any business that directly or indirectly competes with the
business of the Company in the foodservice distribution business in the continental United States. 
 “Consulting
Agreements” means collectively (i) the Consulting Agreement, dated as of July 3, 2007, by and between CD&R and the Company, and (ii) the Consulting Agreement, dated as of July 3, 2007, by and between KKR and the Company, in each case,
as the same may be amended from time to time in accordance with its terms and the terms of this Agreement. 
 “control”
(including the terms “controlling”, “controlled by” and “under common control with”), with respect to the relationship between or among two or more Persons, means the possession, directly or
indirectly, of the power to direct or cause the direction of the affairs or management of a Person, whether through the ownership of voting securities, as trustee or executor, by contract or otherwise. 

“Director” means any member of the Board. 

“Equity Securities” means any and all shares of Common Stock of the Company, securities of the Company convertible into, or
exchangeable or exercisable for, such shares, and options, warrants or other rights to acquire such shares. 
 “Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. 

“Exempt Transaction” means any acquisition or disposition (whether through merger, consolidation or otherwise) (i) which has
a purchase price (including any assumed indebtedness and valuing any non-cash consideration at its Fair Market Value) of less than $25,000,0000 and (ii) which, together with all other Exempt Transactions after the Closing Date has an aggregate
purchase price of less than $50,000,000; provided that no transaction described herein with any Affiliate of any Stockholder shall constitute an Exempt Transaction. 

  
 3 

 “Fair Market Value” means with respect to Common Stock, the average of the
closing sale prices of shares on the stock exchange or national market on which the shares are principally trading for a period of 30 trading days ending on the date in question, and with respect to any other non-cash consideration, the fair market
value of such non-cash consideration as determined in good faith by the Board. 
 “GAAP” means generally accepted
accounting principles, as in effect in the United States of America from time to time. 
 “Group” has the meaning assigned
to such term in Section 13(d)(3) of the Exchange Act. 
 “Indemnification Agreements” means collectively, (i) the
Indemnification Agreement, dated as of July 3, 2007, by and among the Company, CD&R and the CD&R Investors, and (ii) the Indemnification Agreement, dated as of July 3, 2007, by and among the Company, KKR and the KKR Investors, in each case,
as the same may be amended from time to time in accordance with its terms and the terms of this Agreement. 
 “Independent
Director” means a Director who qualifies as “independent” under Rules 303A.01 and 303A.02 of the New York Stock Exchange Listed Company Manual. 

“Investors” means the CD&R Investors and the KKR Investors. 

“IPO” has the meaning set forth in the recitals. 

“KKR” means Kohlberg Kravis Roberts & Co. L.P. 

“KKR Designee” means any Director designated by the KKR Investors pursuant to Section 2.1(a) of this Agreement. 

“KKR Investors” means KKR 2006 Fund L.P., KKR PEI Food Investments L.P., KKR Partners III, L.P., OPERF Co-Investment LLC and
ASF Walter Co-Invest L.P. 
 “Losses” has the meaning assigned to such term in Section 3.1(a). 

“Original Shares” means when used in reference to any one or more Stockholders, the shares of Common Stock held by such
Stockholder on the date hereof, or any shares or other securities which such shares of Common Stock may have been converted into or exchanged for in connection with any exchange, reclassification, dividend, distribution, stock split, combination,
subdivision, merger, spin-off, re-capitalization, re-organization or similar transaction. 
 “Permitted Transferee” means
an Affiliate (other than any “portfolio company” described below) of a Stockholder; provided, however, that in both cases such Transferee shall agree in a writing in the form attached as Exhibit A hereto to be bound by and to
comply with all applicable provisions of this Agreement; provided, further, however, that in no event shall (A) the Company or any of its Subsidiaries, (B) any “portfolio company” (as such term is customarily
used among institutional investors) of any Stockholder or any entity controlled by any portfolio company of any Stockholder or (C) any Company Competitor (whether or not an Affiliate of the Transferring Stockholder) constitute a “Permitted
Transferee”. 

  
 4 

 “Person” means any individual, corporation, limited liability company, limited
or general partnership, joint venture, association, joint-stock company, trust, unincorporated organization, government or any agency or political subdivisions thereof or any Group comprised of two or more of the foregoing. 

“Principal Investors” means Clayton, Dubilier & Rice Fund VII, L.P. and KKR 2006 Fund L.P. 

“Registration Rights Agreement” means the Registration Rights Agreement, dated as of the date hereof, among the Company and
each of the Stockholders, as the same may be amended from time to time in accordance with its terms and the terms of this Agreement. 

“Repurchase” has the meaning assigned to such term in Section 2.5(a)(v). 

“Required Directors” has the meaning assigned to such term in Section 2.5(a). 

“Reserved Employee Shares” means options to purchase Common Stock (and shares of Common Stock issuable upon the exercise
thereof) to employees, officers, directors or consultants pursuant to any stock option, employee stock purchase or similar equity-based plans approved by the Board of Directors or approved by the Board of Directors and the stockholders of the
Company (in each case, as appropriately adjusted for any subsequent stock dividends, combinations, splits or the like), including the 2007 Stock Option Plan for Key Employees of USF Holding Corp. and its Subsidiaries, the US Foods Holding Corp. 2016
Omnibus Incentive Plan and the Employee Stock Purchase Plan. 
 “Securities Act” means the Securities Act of 1933, as
amended, and the rules and regulations promulgated thereunder. 
 “Stockholder” has the meaning set forth in the recitals.

 “Stockholder Designees” has the meaning assigned to such term in Section 2.1(a). 

“Stockholder Indemnitee” has the meaning assigned to such term in Section 3.1(a). 

“Subscription Agreements” means the share subscription agreements entered into on July 3, 2008 between the Company and each
of the Stockholders pursuant to which each of the Stockholders agreed to purchase from the Company shares of Common Stock. 

“Subsidiary” means (i) any corporation of which a majority of the securities entitled to vote generally in the election of
directors thereof, at the time as of which any determination is being made, are owned by another entity, either directly or indirectly, and (ii) any joint venture, general or limited partnership, limited liability company or other legal entity
in which an entity is the record or beneficial owner, directly or indirectly, of a majority of the voting interests or the general partner. 

  
 5 

 “Transfer” means, directly or indirectly, to sell, transfer, assign, pledge,
encumber, hypothecate or similarly dispose of, either voluntarily or involuntarily, or to enter into any contract, option or other arrangement or understanding with respect to the sale, transfer, assignment, pledge, encumbrance, hypothecation or
similar disposition of, any shares of Equity Securities beneficially owned by a Person or any interest in any shares of Equity Securities beneficially owned by a Person. In the event that any Stockholder that is a corporation, partnership, limited
liability company or other legal entity (other than an individual, trust or estate) ceases to be controlled by the Person controlling such Stockholder or a Permitted Transferee thereof, such event shall be deemed to constitute a “Transfer”
subject to the restrictions on Transfer contained or referenced herein. 
 “Transferee” means any Person to whom any
Stockholder or any Transferee thereof Transfers Equity Securities of the Company in accordance with the terms hereof. 

“USF” has the meaning assigned to such term in the recitals. 

“Voting Securities” means, at any time, shares of any class of Equity Securities of the Company, which are then entitled to
vote generally in the election of Directors. 
 SECTION 1.2. Other Definitional Provisions. (a) The words
“hereof,” “herein” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement, and Article and Section
references are to this Agreement unless otherwise specified. 
 (b) The meanings given to terms defined herein shall be equally
applicable to both the singular and plural forms of such terms. 
 ARTICLE II 

CORPORATE GOVERNANCE 

SECTION 2.1. Board Representation. (a) On the Closing Date, the Board shall be comprised of nine directors, with one of such
nine seats vacant, and thereafter, may be comprised of between two and fifteen Directors, but the number of Directors may only be changed with the consent of the CD&R Investors and the KKR Investors for so long as each has the right to designate
a Director pursuant to this Section 2.1(a). On and after the Closing Date, (i) the CD&R Investors, together with their affiliates, shall have the right, but not the obligation, to designate for nomination by the Board as Directors a number of
designees equal to (such Persons, the “CD&R Designees”): (A) at least forty percent (40%) of the total number of Directors comprising the Board at such as time as long as the CD&R Investors (together with their affiliates)
own at least ninety percent (90%) of their Original Shares, of whom, subject to Section 2.4, one shall be designated Chairman of the Board (“Chairman”); (B) at least thirty percent (30%) of the total number of Directors comprising
the Board at such time as long as the CD&R Investors (together with their affiliates) own less than ninety percent (90%) but not less than seventy-five percent (75%) of their Original Shares, of whom, subject to Section 2.4, one shall be
designated Chairman; (C) at least twenty percent (20%) of the total number of Directors 

  
 6 

 
comprising the Board at such time as long as the CD&R Investors (together with their affiliates) own less than seventy-five percent (75%) but not less than fifty percent (50%) of their
Original Shares, of whom, subject to Section 2.4, one shall be designated Chairman; (D) at least ten percent (10%) of the total number of Directors comprising the Board at such time as long as the CD&R Investors (together with their affiliates)
own less than fifty percent (50%) but not less than twenty-five percent (25%) of their Original Shares, of whom, subject to Section 2.4, one shall be designated Chairman; and (E) at least five percent (5%) of the total number of Directors comprising
the Board at such time as long as the CD&R Investors (together with their affiliates) own less than twenty-five percent (25%) but not less than ten percent (10%) of their Original Shares, of whom, subject to Section 2.4, one shall be designated
Chairman; provided that any such Chairman designee pursuant to clauses (A) through (E) shall be an operating partner of CD&R and who shall be entitled to be active in the day-to-day business of the Company and consult with the CEO with
respect thereto for so long as the CD&R Investors deem such consultation to be effective; (ii) the KKR Investors, together with their affiliates, shall have the right, but not the obligation, to designate for nomination by the Board as Directors
a number of designees equal to (such Persons, the “KKR Designees”, and, together with the CD&R Designees, the “Stockholder Designees”): (A) at least forty percent (40%) of the total number of Directors
comprising the Board at such as time as long as the KKR Investors (together with their affiliates) own at least ninety percent (90%) of their Original Shares; (B) at least thirty percent (30%) of the total number of Directors comprising the Board at
such time as long as the KKR Investors (together with their affiliates) own less than ninety percent (90%) but not less than seventy-five percent (75%) of their Original Shares; (C) at least twenty percent (20%) of the total number of Directors
comprising the Board at such time as long as the KKR Investors (together with their affiliates) own less than seventy-five percent (75%) but not less than fifty percent (50%) of their Original Shares; (D) at least ten percent (10%) of the total
number of Directors comprising the Board at such time as long as the KKR Investors (together with their affiliates) own less than fifty percent (50%) but not less than twenty-five percent (25%) of their Original Shares; and (E) at least five percent
(5%) of the total number of Directors comprising the Board at such time as long as the KKR Investors (together with their affiliates) own less than twenty-five percent (25%) but not less than ten percent (10%) of their Original Shares; and (iii) one
designee shall be the CEO (the “CEO Designee”) who shall be designated jointly by the CD&R Investors and the KKR Investors in accordance with Section 2.5(a). 

Effective as of the Closing Date, the CD&R Designees shall initially be John C. Compton, Kenneth A. Giuriceo and Richard J. Schnall, and
John C. Compton shall initially be designated as Chairman, the KKR Designees shall initially be Vishal Patel and Nathaniel H. Taylor, and the CEO Designee shall initially be Pietro Satriano. 

(b) The Company shall take such action as may be required under applicable law to cause the Board to consist of the number of Directors
specified in clause (a). 
 (c) The Company agrees to include in the slate of nominees recommended by the Board the Stockholder
Designees and the CEO Designee and to use its best efforts to cause the election of each such designee to the Board, including nominating such individuals to be elected as Directors as provided herein. 

  
 7 

 (d) In the event that a vacancy is created at any time by the death, disability, retirement,
resignation or removal (with or without cause) of any Director designated pursuant to clause (i), (ii) or (iii) of Section 2.1(a) (or pursuant to the Initial Agreement), the remaining Directors and the Company shall cause the vacancy created thereby
to be filled by a new designee of the CD&R Investors or the KKR Investors, as applicable, who designated such Director as soon as possible, and the Company hereby agrees to take, at any time and from time to time, all actions necessary to
accomplish the same. 
 (e) Each of the Stockholders agrees to vote, or act by written consent with respect to, all Voting Securities
beneficially owned by it, at each annual or special meeting of stockholders of the Company at which Directors are to be elected or to take all actions by written consent in lieu of any such meeting as are necessary, to cause the Stockholder
Designees and the CEO Designee to be elected to the Board. Each of the Stockholders agrees to use its commercially reasonable efforts to cause the election of each such designee to the Board, including nominating such individuals to be elected
as members of the Board. In the event that a vacancy is created at any time by the death, disability, retirement, resignation or removal (with or without cause) of any Director designated pursuant to clause (i), (ii) or (iii) of Section 2.1(a)
(or pursuant to the Initial Agreement) and the remaining Directors pursuant to Section 2.1(d) have caused the vacancy created thereby to be filled by a new designee of the CD&R Investors or KKR Investors, as applicable, then in such case each
Stockholder hereby agrees to take, at any time and from time to time, all actions necessary to accomplish the same. Upon the written request of the CD&R Investors or the KKR Investors, as applicable, each other Stockholder shall vote, or
act by written consent with respect to, all Voting Securities beneficially owned by it and otherwise take or cause to be taken all actions necessary to remove any Director designated by such Stockholders and to elect any replacement Director
designated as provided in this Section 2.1(e). Unless the CD&R Investors or the KKR Investors shall otherwise request in writing, no other Stockholder shall take any action to cause the removal of any Directors designated by such
Stockholders. 
 (f) In the event the CD&R Investors or the KKR Investors, as applicable, shall cease to have the right to
designate a Director in accordance with Section 2.1(a), the designee of such Stockholders selected by such Stockholders shall resign and the Directors remaining in office shall decrease the size of the Board to eliminate such vacancy and no consent
under Section 2.5(a) shall be required in connection with such decrease. 
 (g) The Company shall reimburse each Stockholder Designee
for their reasonable out-of-pocket expenses incurred by them for the purpose of attending meetings of the Board or committees thereof. 

(h) The CD&R Investors and the KKR Investors shall have the right to representation on the board of directors of any Subsidiary in
proportion to their representation on the Board. 
 (i) Following any termination or resignation of the CEO and prior to the hiring of
a replacement CEO pursuant to Section 2.4(c), the CD&R Designee serving as Chairman pursuant to Section 2.1(a)(i) shall be entitled to serve also as CEO on an interim basis until such replacement CEO is hired (during which time the Board
seat to which the CEO Designee is 

  
 8 

 
entitled pursuant to Section 2.1(a)(iii) shall remain vacant). In the event that such CD&R Designee has served as CEO for a period of six months, the continuation of such CD&R
Designee to serve in such position shall require the approval of the Required Directors pursuant to Section 2.5(a)(i).
 (j) In the
event that the size of the Board is expanded to include Independent Directors, the CD&R Investors, on the one hand, and the KKR Investors, on the other hand, shall initially be entitled to designate an equal number of Independent Directors and
each such Independent Director shall be subject to the approval of the non-designating Investor. 
 (k) The rights of the Stockholders
pursuant to this Section 2.1 are personal to the Stockholders and shall not be exercised by any Transferee other than a Permitted Transferee described in clause (ii) of the definition thereof. 

SECTION 2.2. Committees. (a) The Board shall have an Audit Committee, a Compensation Committee and a Nominating and Corporate
Governance Committee, and may form additional committees upon the approval of the Board (each, a “Committee”). The power and authority of each Committee shall be determined from time to time by the Board. 

(b) So long as the CD&R Investors or the KKR Investors, as applicable, have the right to designate at least one (1) Director pursuant
to Section 2.1, the Company shall cause the Audit Committee, the Compensation Committee, the Nominating and Corporate Governance Committee or other significant committee of the Board (including, without limitation, any committee performing the
functions usually reserved for the committees described above) to include at least one (1) CD&R Designee and one (1) KKR Designee; provided that the right of any Director to serve on a Committee shall be subject to applicable law and the
Company’s obligation to comply with any applicable independence requirements of a national securities exchange upon which the Common Stock is listed to which it is then subject. 

SECTION 2.3. [Reserved]. 

SECTION 2.4. Change in CEO. (a) The Principal Investors shall cooperate with each other in good faith to evaluate on a
periodic basis the performance of the CEO and shall use all reasonable efforts to reach mutual agreement with respect to whether replacing the CEO at any time is in the best interests of the Company. 

(b) [Reserved].

(c) Following any termination or resignation of the CEO, the Stockholder Designees shall cause the Board to promptly initiate a search
for a replacement CEO, the hiring of such replacement CEO to require the consent of the Required Directors pursuant to Section 2.5(a)(i). In connection with such search, the Principal Investors shall consider in good faith the need to combine
the titles of Chairman and CEO to the extent necessary to attract the most qualified CEO candidates. Upon the termination or resignation of any Person who holds the title of Chairman and CEO, the CD&R Designee shall be entitled to serve as
both Chairman pursuant to Section 2.1(a)(i) and interim CEO pursuant to Section 2.1(i). Notwithstanding that such CD&R Designee no longer holds the title of Chairman, such designee shall be entitled to continue to be active in the
day-to-day business of the Company as specified in Section 2.1(a)(i). 

  
 9 

 SECTION 2.5. Consent Rights. (a) In addition to any vote or consent of the Board
or the stockholders of the Company required by law or the Charter, and notwithstanding anything in this Agreement to the contrary, the Company shall not, and to the extent applicable, shall not permit any Subsidiary of the Company to, take any of
the following actions, or enter into any arrangement or contract to do any of the following actions, without the consent in writing of at least one CD&R Designee and one KKR Designee (the consent of the “Required Directors”),
which shall be necessary for authorizing, effecting or validating such transactions; provided that if the CD&R Investors or the KKR Investors, as applicable, are no longer entitled to appoint a Stockholder Designee, any such action shall,
subject to Section 2.8(a), require the written consent of the CD&R Investors or the KKR Investors, as applicable: 
 (i) except as
provided in Section 2.4, the selection, hiring, termination or removal of the CEO, any Person hired to replace the CEO, the continuation of a CD&R Designee as interim CEO for a period of greater than six months, and any determination of the
compensation of the CEO of the Company or his or her direct reports; 
 (ii) any (A) merger or consolidation with or into any other Person,
or any acquisition of another Person, whether in a single transaction or a series of related transactions, other than any Exempt Transaction, (B) proposed transaction or series of related transactions involving a Change of Control of the Company, or
(C) proposed Transfer by a Stockholder except to a Permitted Transferee; 
 (iii) the incurrence of indebtedness for borrowed money
(including through capital leases, the issuance of debt securities or the guarantee of indebtedness of another Person) other than the incurrence of trade payables arising in the ordinary course of operating the business; 

(iv) any authorization, creation (by way of reclassification, merger, consolidation or otherwise) or issuance of any securities of the Company
and for the avoidance of doubt, in connection with an Exempt Transaction), other than (A) the issuance of Reserved Employee Shares, or (B) the issuance of any securities as consideration in, or in connection with, a transaction approved pursuant to
Sections 2.5(a)(ii) or (xiii); 
 (v) any redemption, acquisition or other purchase of any shares of Common Stock (a
“Repurchase”) other than a Repurchase from an employee (not including the CEO) in connection with such employee’s termination of employment with the Company or any Subsidiary; 

(vi) any payment or declaration of any dividend or other distribution on any shares of Common Stock or entering into any recapitalization
transaction the primary purpose of which is to pay a dividend; 
 (vii) the creation of any non-wholly owned subsidiaries, or the Transfer or
any sale or Transfer of a Subsidiary’s securities to any Person other than the Company or a wholly owned Subsidiary of the Company (other than any pledge of such Subsidiary’s stock pursuant to a financing approved by the Board in
accordance with Section 2.5(a)(iii); 

  
 10 

 (viii) the creation or amendment of any stock option, employee stock purchase or similar
equity-based plan for management or employees, or any increase in the number of Reserved Employee Shares; 
 (ix) [intentionally omitted];

 (x) any transaction with or involving any Affiliate of the Company or any Affiliate of any stockholder of the Company that beneficially
owns in excess of ten percent (10%) of the voting power of the Company, other than (A) a Transfer to a Permitted Transferee, (B) the Consulting Agreements, the Registration Rights Agreement and the Indemnification Agreements, but including any
amendment, termination or material waiver under any such agreements, or (C) any transaction or series of related transactions in the ordinary course of business and on arms-length third-party terms with any “portfolio company” (as such
term is customarily used among institutional investors) held or managed by any Affiliate of the Company and not involving amounts in excess of $5,000,000 per annum; 

(xi) any amendment, repeal or alteration of the Charter or the Bylaws or any organizational documents of any Subsidiary, whether by or in
connection with a merger or consolidation or otherwise; 
 (xii) any increase or decrease in the size or composition of the Board, committees
of the Board, and boards and committees of Subsidiaries of the Company and any termination or removal of an Independent Director; 
 (xiii)
any (A) acquisition of the stock or assets of any Person, or the acquiring by any other manner of any business, properties, assets, or Persons, in one transaction or a series of related transactions, or (B) dispositions of assets of the Company or
any Subsidiary, other than, in either case, an Exempt Transaction; 
 (xiv) [intentionally omitted]; 

(xv) any voluntary election by the Company or any Subsidiary of the Company to liquidate or dissolve or to commence bankruptcy or insolvency
proceedings or the adoption of a plan with respect to any of the foregoing; 
 (xvi) any material change in a significant accounting policy
of the Company and any termination or change of the Company’s independent auditor; 
 (xvii) [intentionally omitted]; 

(xviii) [intentionally omitted]; 

(xix) [intentionally omitted]; 

  
 11 

 (xx) the grant of registration rights to any Stockholder (including any Permitted Transferee of a
Stockholder), other than (A) the transfer of demand registration rights permitted by the Registration Rights Agreement or (B) the grant of piggyback registration rights pursuant to any agreement entered into with any management stockholder after the
date hereof in the ordinary course; 
 (xxi) [intentionally omitted]; 

(xxii) the deregistration of the Company pursuant to Section 7 of the Registration Rights Agreement; 

(xxiii) settlement of any litigation to which the Company or any of its Subsidiaries is a party involving the payment by the Company or any of
its Subsidiaries of an amount equal to or greater than $15 million; 
 (xxiv) making a material tax election or entering into any agreement
in respect of taxes, including the settlement of any material tax controversy, or similar action relating to the filing of any tax return or the payment of any tax, if such election, agreement or action would reasonably be expected to result in any
direct tax liability for any of the Stockholders or any direct or indirect holder of equity in any of the Stockholders; and 
 (xxv) any
material change in the nature of the business of the Company or any Subsidiary, taken as a whole. 
 (b) In connection with any vote or
action by written consent of the stockholders of the Company relating to any matter requiring consent as specified in Section 2.5(a), each Stockholder agrees, with respect to any Voting Securities beneficially owned by such Stockholder with respect
to which it has the power to vote, (i) to vote against (and not act by written consent to approve) such matter if such matter has not been consented to by the Required Directors in accordance with Section 2.5(a) and (ii) to take or cause to be
taken, upon the written request of the CD&R Investors (if such matter has not been consented to by a CD&R Designee) or the KKR Investors (if such matter has not been consented to by a KKR Designee), all other reasonable actions, at the
expense of the Company, required, to the extent permitted by law, to prevent the taking of any action by the Company with respect to a matter unless such matter has been consented to by the Required Directors in accordance with Section 2.5(a).

 (c) Each Stockholder (i) that is a Permitted Transferee, an Affiliate co-investor or a co-investment vehicle hereby irrevocably
grants to and appoints the Principal Investor which is an Affiliate of such Stockholder and (ii) that is not a Person described in clause (i), hereby irrevocably grants to and appoints the Principal Investors collectively (to act by unanimous
consent) such Stockholder’s proxy and attorney-in-fact (with full power of substitution), for and in the name, place and stead of such Stockholder, to vote or act by written consent with respect to such Stockholder’s Common Stock, and to
grant a consent, proxy or approval in respect of such Common Stock, in the event that such Stockholder fails at any time to vote or act by written consent with respect to any of its Common Stock in the manner agreed by such Stockholder in this
Agreement, in each case in accordance with such Stockholder’s agreements contained in this 

  
 12 

 
Agreement. Each Stockholder (other than the Principal Investors) hereby affirms that the irrevocable proxy set forth in this Section 2.5(c) will be valid for the term of this Agreement
and is given to secure the performance of the obligations of such Stockholder under this Agreement. Each such Stockholder hereby further affirms that each proxy hereby granted shall be irrevocable and shall be deemed coupled with an interest
and shall extend for the term of this Agreement, or, if earlier, until the last date permitted by applicable law. For the avoidance of doubt, except as expressly contemplated by this Section 2.5(c), none of the Stockholders has been granted a
proxy to any Person to exercise the rights of any such Stockholder under this Agreement or any other agreement to which such Stockholders is a party. 

SECTION 2.6. Available Financial Information. (a) Upon the written request of such Stockholder, the Company will
deliver, or will cause to be delivered, the information set forth in clauses (iii) and (iv) to each requesting Stockholder and, and upon the written request of any Principal Investor, the information listed in clause (i) and (ii) to such Principal
Investor and any transferee of a CD&R Investor or a KKR Investor which holds shares of Common Stock that constitute at least twenty-five percent (25%) of the Original Shares of the CD&R Investors or the KKR Investors, as applicable, until
such time as such Stockholder and its Affiliates shall cease to own any shares of Common Stock: 
 (i) as soon as available
after the end of each month and in any event within thirty (30) days thereafter, a consolidated balance sheet of the Company and its Subsidiaries as of the end of such month and consolidated statements of operations, income, cash flows, retained
earnings and stockholders’ equity of the Company and its Subsidiaries, for each month and for the current fiscal year of the Company to date, prepared in accordance with GAAP (subject to normal year-end audit adjustments and the absence of
notes thereto), together with a comparison of such statements to the corresponding periods of the prior fiscal year and to the Company’s business plan then in effect and approved by the Board; 

(ii) an annual budget, a business plan and financial forecasts for the Company for the next fiscal year of the Company (the
“Annual Budget”), no later than thirty (30) days before the beginning of the Company’s next fiscal year, in such manner and form as approved by the Board, which shall include at least a projection of income and a projected cash
flow statement for each fiscal quarter in such fiscal year and a projected balance sheet as of the end of each fiscal quarter in such fiscal year, in each case prepared in reasonable detail, with appropriate presentation and discussion of the
principal assumptions upon which such budgets and projections are based, which shall be accompanied by the statement of the chief executive officer or chief financial officer or equivalent officer of the Company to the effect that such budget and
projections are based on reasonable and good faith estimates and assumptions made by the management of the Company for the respective periods covered thereby; it being recognized by such holders that such budgets and projections as to future events
are not to be viewed as facts and that actual results during the period or periods covered by them may differ from the projected results. Any material changes in such Annual Budget shall be delivered to the Stockholders as promptly as
practicable after such changes have been approved by the Board; 

  
 13 

 (iii) as soon as available after the end of each fiscal year of the Company, and
in any event within ninety (90) days thereafter, (A) the annual financial statements required to be filed by the Company pursuant to the Exchange Act or (B) a consolidated balance sheet of the Company and its Subsidiaries as of the end of such
fiscal year, and consolidated statements of income, retained earnings and cash flows of the Company and its Subsidiaries for such year, prepared in accordance with GAAP and setting forth in each case in comparative form the figures for the previous
fiscal year, all in reasonable detail and accompanied by the opinion of independent public accountants of recognized national standing selected by the Company, and a Company-prepared comparison to the Company’s Annual Budget for such year as
approved by the Board; and 
 (iv) as soon as available after the end of the first, second and third quarterly accounting
periods in each fiscal year of the Company, and in any event within forty-five (45) days thereafter, (A) the quarterly financial statements required to be filed by the Company pursuant to the Exchange Act or (B) a consolidated balance sheet of the
Company and its Subsidiaries as of the end of each such quarterly period, and consolidated statements of income, retained earnings and cash flows of the Company and its Subsidiaries for such period and for the current fiscal year to date, prepared
in accordance with GAAP (subject to normal year-end audit adjustments and the absence of notes thereto) and setting forth in comparative form the figures for the corresponding periods of the previous fiscal year and to the Company’s Annual
Budget then in effect as approved by the Board, all in reasonable detail and certified by the principal financial or accounting officer of the Company.  

(b) Other Information. The Company covenants and agrees to deliver to each Stockholder, upon written request, so long as such
Stockholder owns at least five percent (5%) of the outstanding shares of Common Stock, with reasonable promptness, such other information and data (including such information and reports made available to any lender of the Company or any of its
Subsidiaries under any credit agreement or otherwise) with respect to the Company and each of its Subsidiaries as from time to time may be reasonably requested by any such Stockholder; provided that the Company reserves the right to withhold
any information under this Section 2.6(b) or access under Section 2.7 from a Stockholder if the Board determines that providing such information or granting such access would reasonably be expected to adversely affect the Company on a competitive
basis or otherwise. Each such Stockholder shall have access to such other information concerning the Company’s business or financial condition and the Company’s management as may be reasonably requested, including all rights necessary to
satisfy VCOC requirements applicable to such Stockholder. 
 SECTION 2.7. Access. The Company shall, and shall cause its
Subsidiaries, officers, directors, employees, auditors and other agents to, until such time as an Stockholder shall cease to own any shares of Common Stock, (a) afford the officers, employees, auditors and other agents of such Stockholder, during
normal business hours and upon reasonable notice reasonable access at all reasonable times to its officers, employees, auditors, legal counsel, properties, offices, plants and other facilities and to all books and records, and (b) afford such
Stockholder the opportunity to discuss the affairs, finances and accounts of the Company and its Subsidiaries with their respective officers from time to time as each such Stockholder may reasonably request. 

  
 14 

 SECTION 2.8. Termination of Rights. Notwithstanding Sections 2.4 and 2.5,
at such time as the CD&R Investors or the KKR Investors, as applicable, together with their respective Affiliates, shall cease to own a number of shares of Common Stock equal to at least ten percent (10%) of the outstanding shares of Common
Stock, the CD&R Investors or the KKR Investors, as applicable, shall cease to have any rights under Sections 2.4 and 2.5. 
 ARTICLE
III 
 MISCELLANEOUS 

SECTION 3.1. Stockholder Indemnification; Reimbursement of Expenses.

(a) The Company agrees to indemnify and hold harmless each Stockholder, their respective directors, members, managers and officers and
their Affiliates (the Stockholders, and the respective directors, officers, partners, members, managers, Affiliates and controlling persons thereof, each, an “Stockholder Indemnitee”) from and against any and all liability,
including, without limitation, all obligations, costs, fines, claims, actions, injuries, demands, suits, judgments, proceedings, investigations, arbitrations (including stockholder claims, actions, injuries, demands, suits, judgments, proceedings,
investigations or arbitrations) and reasonable expenses, including reasonable accountant’s and reasonable attorney’s fees and expenses (together the “Losses”), incurred by such Stockholder Indemnitee before or after the
date of this Agreement and arising out of, resulting from, or relating to (i) such Stockholder Indemnitee’s purchase and/or ownership of any Equity Securities, (ii) the transactions contemplated by the Subscription Agreement to which it is a
party (including the agreements described therein), and any other subscription agreements pursuant to which any Stockholder Indemnitee purchased securities of the Company and all agreements contemplated thereby, or (iii) any litigation to which any
Stockholder Indemnitee is made a party in its capacity as a stockholder or owner of securities (or a partner, director, officer, member, manager, Affiliate or controlling person of any Stockholder Indemnitee) of the Company; provided that the
foregoing indemnification rights in this Section 3.1 shall not be available to the extent that (a) any such Losses are incurred as a result of such Stockholder Indemnitee’s willful misconduct or gross negligence; (b) any such Losses are
incurred as a result of non-compliance by such Stockholder Indemnitee with any laws or regulations applicable to any of them; (c) any such Losses are incurred as a result of non-compliance by such Stockholder Indemnitee with its obligations under
any of the agreements or instruments referenced above or any other agreements or instruments to which such Stockholder Indemnitee is or becomes a party or otherwise becomes bound; or (d) subject to the rights of contribution provided for below, to
the extent indemnification for any Losses would violate any applicable law, regulation or public policy. For purposes of this Section 3.1, none of the circumstances described in the limitations contained in the proviso in the immediately preceding
sentence shall be deemed to apply absent a final non-appealable judgment of a court of competent jurisdiction to such effect, in which case to the extent any such limitation is so determined to apply to any Stockholder Indemnitee as to any
previously advanced indemnity payments made by the Company under this Section 3.1, then such payments shall be promptly 

  
 15 

 
repaid by such Stockholder Indemnitee to the Company. The rights of any Stockholder Indemnitee to indemnification hereunder will be in addition to any other rights any such party may have
under any other agreement or instrument referenced above or any other agreement or instrument to which such Stockholder Indemnitee is or becomes a party or is or otherwise becomes a beneficiary or under law or regulation. In the event of any
payment of indemnification pursuant to this Section 3.1, so long as any Stockholder Indemnitee is fully indemnified for all Losses, the Company will be subrogated to the extent of such payment to all of the related rights of recovery of the
Stockholder Indemnitee to which such payment is made against all other Persons. Such Stockholder Indemnitee shall execute all papers reasonably required to evidence such rights. The Company will be entitled at its election to participate
in the defense of any third party claim upon which indemnification is due pursuant to this Section 3.1 or to assume the defense thereof, with counsel reasonably satisfactory to such Stockholder Indemnitee unless, in the reasonable judgment of the
Stockholder Indemnitee, a conflict of interest between the Company and such Stockholder Indemnitee may exist, in which case such Stockholder Indemnitee shall have the right to assume its own defense and the Company shall be liable for all reasonable
expenses therefor. Except as set forth above, should the Company assume such defense all further defense costs of the Stockholder Indemnitee in respect of such third party claim shall be for the sole account of such party and not subject to
indemnification hereunder. The Company will not without the prior written consent of the Stockholder Indemnitee effect any settlement of any threatened or pending third party claim in which such Stockholder Indemnitee is or could have been a
party and be entitled to indemnification hereunder unless such settlement solely involves the payment of money and includes an unconditional release of such Stockholder Indemnitee from all liability and claims that are the subject matter of such
claim. If the indemnification provided for above is unavailable in respect of any Losses, then the Company, in lieu of indemnifying an Stockholder Indemnitee, shall contribute to the amount paid or payable by such Stockholder Indemnitee in such
proportion as is appropriate to reflect the relative fault of the Company and such Stockholder Indemnitee in connection with the actions which resulted in such Losses, as well as any other equitable considerations. 

The Company agrees to pay or reimburse (i) the Stockholders for (A) all reasonable costs and expenses (including reasonable attorneys fees,
charges, disbursement and expenses) incurred in connection with any amendment, supplement, modification or waiver of or to any of the terms or provisions of this Agreement or any related agreements and (B) in connection with any stamp, transfer,
documentary or other similar taxes, assessments or charges levied by any governmental or revenue authority in respect of this Agreement or any related agreements; and (ii) each Stockholder for all costs and expenses of such Stockholder (including
reasonable attorneys fees, charges, disbursement and expenses) incurred in connection with (1) the consent to any departure by the Company or any of its Subsidiaries from the terms of any provision of this Agreement or any related agreements
and (2) the enforcement or exercise by such Stockholder of any right granted to it or provided for hereunder. 
 SECTION
3.2. Termination. Subject to the early termination of any provision as a result of an amendment to this Agreement agreed to by the Board and the Stockholders as provided under Section 3.3 (i) the provisions of Article II shall,
with respect to each Stockholder, terminate as provided in the applicable Section of Article II or, if not so provided, as provided in Section 2.8 and (ii) Section 3.1 of this Agreement shall not terminate. Nothing herein shall
relieve any party from any liability for the breach of any of the agreements set forth in this Agreement. 

  
 16 

 SECTION 3.3. Amendments and Waivers. (a) Except as otherwise provided herein, no
modification, amendment or waiver of any provision of this Agreement shall be effective without the approval of the Board and each of the CD&R Investors and the KKR Investors; provided, that any Stockholder may waive (in writing) the
benefit of any provision of this Agreement with respect to itself for any purpose. The failure of any party to enforce any of the provisions of this Agreement shall in no way be construed as a waiver of such provisions and shall not affect the
right of such party thereafter to enforce each and every provision of this Agreement in accordance with its terms. Any written amendment or waiver to this Agreement that receives the vote or consent of the Stockholders provided herein need not
be signed by all Stockholders, but shall be effective in accordance with its terms and shall be binding upon all Stockholders. 
 SECTION
3.4. Successors, Assigns and Transferees. This Agreement shall bind and inure to the benefit of and be enforceable by the parties hereto and their respective successors and permitted assigns. Stockholders may assign their
respective rights and obligations hereunder to any Transferees only to the extent expressly provided herein. 
 SECTION
3.5. [Reserved]. 
 SECTION 3.6. Notices. All notices and other communications required or permitted
hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified; (b) when sent by confirmed facsimile if sent during normal business hours of the recipient, if not, then on the next
Business Day, provided that a copy of such notice is also sent via nationally recognized overnight courier, specifying next day delivery, with written verification of receipt; (c) five days after having been sent by registered or certified mail,
return receipt requested, postage prepaid; or (d) one Business Day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to such
party’s address as set forth below or at such other address as the party shall have furnished to each other party in writing in accordance with this provision: 

if to the Company, to: 
 US Foods
Holding Corp. 
 9399 W. Higgins Road, Suite 500 

Rosemont, Illinois 60018 

Attention: Juliette W. Pryor, Esq. 

Facsimile: (847) 720-8000 
 with a
copy (which shall not constitute notice) to: 
 Kohlberg Kravis Roberts & Co. L.P. 

2800 Sand Hill Road, Suite 94025 

Menlo Park, California 94025 

Attention: Nathaniel H. Taylor 

Facsimile: 650-233-6561 

  
 17 

 and 

Clayton, Dubilier & Rice, Inc. 

375 Park Avenue 
 18th Floor 
 New York, New York 10152 

Attention: Richard J. Schnall 

Facsimile: (212) 407-5252 
 with a
copy (which shall not constitute notice) to: 
 Jenner & Block LLP 

919 Third Avenue 
 New York, New
York 10022 
 Attention: Kevin T. Collins 

Facsimile: (212) 891-1699 
 and

 Debevoise & Plimpton LLP 

919 Third Avenue 
 New York, New
York 10022 
 Attention: Steven J. Slutzky, Esq. 

Facsimile: (212) 909-6036 
 and

 Simpson Thacher & Bartlett LLP 

425 Lexington Avenue 
 New York,
New York 10017 
 Attention: Marnie Lerner 

Facsimile: (212) 455-2502 
 if to
a KKR Investor, to: 
 Kohlberg Kravis Roberts & Co. L.P. 

2800 Sand Hill Road, Suite 94025 

Menlo Park, California 94025 

Attention: Nathaniel H. Taylor 

Facsimile: 650-233-6561 
 with a
copy (which shall not constitute notice) to: 
 Simpson Thacher & Bartlett LLP 

425 Lexington Avenue 
 New York,
New York 10017 
 Attention: Marnie Lerner 

Facsimile: (212) 455-2502 

  
 18 

 if to a CD&R Investor, to: 

Clayton, Dubilier & Rice, Inc. 

375 Park Avenue 
 18th Floor 
 New York, New York 10152 

Attention: Richard J. Schnall 

Facsimile: (212) 407-5252 
 with a
copy (which shall not constitute notice) to: 
 Debevoise & Plimpton LLP 

919 Third Avenue 
 New York, New
York 10022 
 Attention: Steven J. Slutzky, Esq. 

Facsimile: (212) 909-6036 

SECTION 3.7. Further Assurances. At any time or from time to time after the date hereof, the parties agree to cooperate with
each other, and at the request of any other party, to execute and deliver any further instruments or documents and to take all such further action as the other party may reasonably request in order to evidence or effectuate the consummation of the
transactions contemplated hereby and to otherwise carry out the intent of the parties hereunder.
 SECTION 3.8. Entire
Agreement. Except as otherwise expressly set forth herein, this Agreement together with the Registration Rights Agreement and the Subscription Agreements embody the complete agreement and understanding among the parties hereto with respect
to the subject matter hereof and supersedes and preempts any prior understandings, agreements or representations by or among the parties, written or oral, that may have related to the subject matter hereof in any way.

SECTION 3.9. Restrictions on Other Agreements; Bylaws. (a) Following the date hereof, no Stockholder or any of its, her
or his Permitted Transferees shall enter into or agree to be bound by any stockholder agreements or arrangements of any kind with any Person with respect to any Equity Securities except pursuant to the agreements specifically contemplated by the
Subscription Agreement to which it is a party and the Registration Rights Agreement. 
 (b) The provisions of this Agreement shall be
controlling if any such provisions or the operation thereof conflict with the provisions of the Company’s Bylaws. Each of the parties covenants and agrees to vote their Equity Securities and to take any other action reasonably requested by the
Company or any Stockholder to amend the Company’s Bylaws so as to avoid any conflict with the provisions hereof. 

  
 19 

 SECTION 3.11. Delays or Omissions. It is agreed that no delay or omission to exercise
any right, power or remedy accruing to any party, upon any breach, default or noncompliance by another party under this Agreement, shall impair any such right, power or remedy, nor shall it be construed to be a waiver of any such breach, default or
noncompliance, or any acquiescence therein, or of or in any similar breach, default or noncompliance thereafter occurring. It is further agreed that any waiver, permit, consent or approval of any kind or character on the part of any party hereto of
any breach, default or noncompliance under this Agreement or any waiver on such party’s part of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing.
All remedies, either under this Agreement, by law, or otherwise afforded to any party, shall be cumulative and not alternative. 
 SECTION
3.12. Governing Law; Jurisdiction; Waiver of Jury Trial. This Agreement shall be governed in all respects by the laws of the State of New York regardless of the law that might be applied under principles of conflict of laws to the
extent such principles would require or permit the application of the laws of another jurisdiction. No suit, action or proceeding with respect to this Agreement may be brought in any court or before any similar authority other than in a court
of competent jurisdiction in the State of New York, and the parties hereto hereby submit to the exclusive jurisdiction of such courts for the purpose of such suit, proceeding or judgment. Each party hereto hereby irrevocably waives any right it
may have had to bring such an action in any other court, domestic or foreign, or before any similar domestic or foreign authority. Each of the parties hereto hereby irrevocably and unconditionally waives trial by jury in any legal action or
proceeding in relation to this Agreement and for any counterclaim therein. 
 SECTION 3.13. Severability. Whenever
possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any
applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision or any other jurisdiction, but this Agreement shall be reformed, construed and enforced in such jurisdiction as if such
invalid, illegal or unenforceable provision had never been contained herein. 
 SECTION 3.14. Enforcement. Each party
hereto acknowledges that money damages would not be an adequate remedy in the event that any of the covenants or agreements in this Agreement are not performed in accordance with its terms, and it is therefore agreed that in addition to and without
limiting any other remedy or right it may have, the non-breaching party will have the right to an injunction, temporary restraining order or other equitable relief in any court of competent jurisdiction enjoining any such breach and enforcing
specifically the terms and provisions hereof. 
 SECTION 3.15. Titles and Subtitles. The titles of the sections and
subsections of this Agreement are for convenience of reference only and are not to be considered in construing this Agreement. 
 SECTION
3.16. No Recourse. Notwithstanding anything that may be expressed or implied in this Agreement, the Company and each Stockholder covenant, agree and 

  
 20 

 
acknowledge that no recourse under this Agreement or any documents or instruments delivered in connection with this Agreement shall be had against any current or future director, officer,
employee, general or limited partner or member of any Stockholder or of any Affiliate or assignee thereof, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any statute, regulation or other
applicable law, it being expressly agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on or otherwise be incurred by any current or future officer, agent or employee of any Stockholder or any current or future
member of any Stockholder or any current or future director, officer, employee, partner or member of any Stockholder or of any Affiliate or assignee thereof, as such for any obligation of any Stockholder under this Agreement or any documents or
instruments delivered in connection with this Agreement for any claim based on, in respect of or by reason of such obligations or their creation. 

SECTION 3.17. Counterparts; Facsimile Signatures. This Agreement may be executed in any number of counterparts, each of which
shall be an original, but all of which together shall constitute one instrument. This Agreement may be executed by facsimile signature(s). 

[Rest of page intentionally left blank] 

  
 21 

 IN WITNESS WHEREOF, the parties hereto have executed this Stockholders Agreement as of the date
set forth in the first paragraph hereof. 
  

					
	US FOODS HOLDING CORP.
		
	By:	 	 /s/ Juliette Pryor

		 	Name:	 	Juliette Pryor
		 	Title:	 	Executive Vice President, General Counsel and Secretary

  
 [Signature Page to US
Foods Holding Corp. Amended and Restated Stockholders Agreement] 

					
	KKR 2006 FUND L.P.
		
	By:	 	KKR Associates 2006 L.P.,
		 	its General Partner
		
	By:	 	KKR 2006 GP LLC,
		 	its General Partner
		
	By:	 	 /s/ William J. Janetschek

		 	Name:	 	William J. Janetschek
		 	Title:	 	Vice President
	
	KKR PEI FOOD INVESTMENTS L.P.
		
	By:	 	KKR PEI Food Investments GP LLC,
		 	its General Partner
		
	By:	 	 /s/ William J. Janetschek

		 	Name:	 	William J. Janetschek
		 	Title:	 	Chief Financial Officer
	
	KKR PARTNERS III, L.P.
		
	By:	 	KKR III GP LLC,
		 	its General Partner
		
	By:	 	 /s/ William J. Janetschek

		 	Name:	 	William J. Janetschek
		 	Title:	 	Authorized Person
	
	OPERF CO-INVESTMENT LLC
		
	By:	 	KKR Associates 2006 L.P.,
		 	its Manager
		
	By:	 	KKR 2006 GP LLC,
		 	its General Partner
		
	By:	 	 /s/ William J. Janetschek

		 	Name:	 	William J. Janetschek
		 	Title:	 	Vice President

  
 [Signature Page to US
Foods Holding Corp. Amended and Restated Stockholders Agreement] 

 
					
	ASF WALTER CO-INVEST L.P.
		
	By:	 	ASF Walter Co-Invest GP Limited,
		 	its General Partner
		
	By:	 	 /s/ William J. Janetschek

		 	Name:	 	William J. Janetschek
		 	Title:	 	Director

  
 [Signature Page to US
Foods Holding Corp. Amended and Restated Stockholders Agreement] 

					
	CLAYTON, DUBILIER & RICE FUND VII, L.P.
		
	By:	 	CD&R Associates VII, Ltd.,
		 	its General Partner
		
	By:	 	 /s/ Theresa A. Gore

		 	Name:	 	Theresa A. Gore
		 	Title:	 	Vice President, Treasurer & Assistant Secretary
	
	CLAYTON, DUBILIER & RICE FUND VII (CO-
	INVESTMENT), L.P.
		
	By:	 	CD&R Associates VII (Co-Investment), Ltd.,
		 	its General Partner
		
	By:	 	 /s/ Theresa A. Gore

		 	Name:	 	Theresa A. Gore
		 	Title:	 	Vice President, Treasurer & Assistant Secretary
	
	CD&R PARALLEL FUND VII, L.P.
		
	By:	 	CD&R Parallel Fund Associates VII, Ltd.,
		 	its General Partner
		
	By:	 	 /s/ Theresa A. Gore

		 	Name:	 	Theresa A. Gore
		 	Title:	 	Vice President, Treasurer & Assistant Secretary
	
	CDR USF CO-INVESTOR L.P.
		
	By:	 	CDR USF Co-Investor GP Limited,
		 	its General Partner
		
	By:	 	 /s/ Theresa A. Gore

		 	Name:	 	Theresa A. Gore
		 	Title:	 	Vice President, Treasurer & Assistant Secretary

  
 [Signature Page to US
Foods Holding Corp. Amended and Restated Stockholders Agreement] 

 
					
	CDR USF CO-INVESTOR NO. 2, L.P.
		
	By:	 	CDR USF Co-Investor GP No. 2 Limited, its
		 	General Partner
		
	By:	 	 /s/ Theresa A. Gore

		 	Name:	 	Theresa A. Gore
		 	Title:	 	Vice President, Treasurer & Assistant Secretary

  
 [Signature Page to US
Foods Holding Corp. Amended and Restated Stockholders Agreement] 

 Exhibit A 

Assignment and Assumption Agreement 

Pursuant to the Amended and Restated Stockholders Agreement, dated as of June 1, 2016 (the “Stockholders Agreement”), among
US Foods Holding Corp., a Delaware corporation (the “Company”), and each of the stockholders of the Company whose name appears on the signature pages listed therein (each, a “Stockholder” and collectively, the
“Stockholders”),                      (the “Transferor”) hereby assigns to the undersigned the rights that may be
assigned thereunder, and the undersigned hereby agrees that, having acquired Equity Securities as permitted by the terms of the Stockholders Agreement, the undersigned shall assume the obligations of the Transferor under the Stockholders Agreement.
Capitalized terms used but not defined herein shall have the meanings assigned to them in the Stockholders Agreement. 
 Listed below is
information regarding the Equity Securities: 
  

			
	 Number of Shares of

Common Stock
	  	 
		  	

 [Rest of page intentionally left blank] 

 IN WITNESS WHEREOF, the undersigned has executed this Assumption Agreement as
of                 ,         . 
  

	
	[NAME OF TRANSFEREE]
	
	  

	Name:
	Title:

 Acknowledged by: 
  

			
	US FOODS HOLDING CORP.
		
	By:	 	  

		 	Name:
		 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00259-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00259-of-00352.parquet"}]]